Table 4 The occurrence of risk factors in different degrees of SLE flare
|
Mild or moderate SLE flare (n = 28) |
Severe SLE flare (n = 93) | P-value | |
|---|---|---|---|
| Infection | 7(25.0) | 47(50.5) | 0.019 |
| Arthritis, n (%) | 16(57.1) | 51(54.8) | 1.000 |
| Thrombocytopenia, n (%) | 6(21.4) | 13(14.0) | 0.378 |
| Anti-nucleosome antibody, n (%) | 9(32.1) | 37(39.8) | 0.513 |
| anti-β2-glycoprotein I antibody (IgG), n (%) | 5(17.9) | 15(16.1) | 0.779 |
| Use immunosuppressant for initial treatment, n (%) | 8(28.6) | 41(44.1) | 0.188 |
| Use Hydroxychloroquine for initial treatment, n (%) | 21(75.0) | 77(82.8) | 0.412 |
| patient’s self-discontinuation of medicine maintenance therapy, n (%) | 10(35.7) | 55(59.1) | 0.033 |